|Videos|June 15, 2022
Clinical Implications of the TIVO-3 Trial
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
5